Drug Research
Eisai enters joint research pact with four research organizations in Japan for development of therapeutics for novel COVID-19
Eisai Co Ltd announced that it has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global...
News
Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis
Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for SB11,...
News
Gilead takes over distribution of Covid-19 antiviral drug from federal government
The maker of the first antiviral drug to get authorization from regulators for Covid-19 anticipates meeting real-time demand for it around the world this...
Clinical Trials
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy Trial - Intent to...
Press Releases
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
Pfizer Inc. and BioNTech SE announced the initiation of a rolling submission to the European Medicines Agency (EMA) for BNT162b2, the lead candidate from...
News
DuPont to Virtually Showcase Technical Expertise and Commitment to Pharmaceutical Customers at CPhI: Festival of Pharma
DuPont announced it will participate in the virtual CPhI: Festival of Pharma, highlighting its commitment to meet customers’ needs for essential innovations to address...
News
Dr. Reddy’s Laboratories Goes Paperless in Validation with ValGenesis VLMS
ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), announced that it has digitized the validation process at Dr. Reddy's Laboratories...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read